Christopher R. Frei is an Associate Professor in the Division of Pharmacotherapy, College of Pharmacy, The University of Texas, Austin, Texas and an Adjoint Faculty Member, Pharmacotherapy Education and Research Center (PERC), School of Medicine, the University of Texas Health Science Center, San Antonio, Texas. Dr. Frei completed his Doctor of Pharmacy degree (2001), Master’s degree (2003), residency (2003), and post-doctoral training (2005) at the UT Austin and the UT Health Science Center. He joined the faculty at both universities in January 2006. 

Dr. Frei is a Board Certified Pharmacotherapy Specialist who studies clinically important infectious diseases, including pneumonia, skin and soft tissue infections, and HIV. He is particularly interested in emerging antibiotic resistance among Gram-positive bacteria including Staphylococcus aureus.  His research approach involves pharmacoepidemiology, comparative-effectiveness, and microbial genomics. Dr. Frei has been a principal investigator/co-investigator for 12 different studies supported by NIH, the Society of Infectious Diseases Pharmacists, and the pharmaceutical industry. He has published 59 peer-reviewed papers in leading medical and scientific journals, including the American Journal of Medicine, Antimicrobial Agents in Chemotherapy, Chest, Clinical Microbiology and Infection, Drugs, Pharmacotherapy, Journal of Antimicrobial Chemotherapy, and the Journal of the American Board of Family Medicine. He has also given more than 260 national, state, and local presentations.

In 2011, Dr. Frei was recognized as "Mentor of the Year" by the Texas Society of Health System Pharmacists, "Young Investigator of the Year" by the Society of Infectious Diseases Pharmacists, and "Distinguished Young Alumnus of the Year" by the UT Austin College of Pharmacy. In 2012, he was promoted to Associate Professor with Tenure at the UT Austin.